In 2018, the National Cancer Institute and NRG Oncology partnered for the first time to host a
joint workshop on systemic radiopharmaceutical therapy (RPT) to specifically address …

The use of radiopharmaceutical therapies (RPTs) in the treatment of cancers is growing
rapidly, with more agents becoming available for clinical use in last few years and many new …

Radiopharmaceutical therapy (RPT) continues to demonstrate tremendous potential in
improving the therapeutic gains in radiation therapy by specifically delivering radiation to …

Radiopharmaceutical therapy (RPT) involves the use of radionuclides that are either
conjugated to tumor-targeting agents (eg, nanoscale constructs, antibodies, peptides, and …

Internal dosimetry evaluates the amount and spatial and temporal distributions of radiation
energy deposited in tissue from radionuclides within the body. Historically, nuclear medicine …

Precision medicine is the selection of a treatment modality that is specifically tailored to the
genetic and phenotypic characteristics of a particular patient's disease. In cancer, the …

In radiopharmaceutical therapy (RPT), a radionuclide is systemically or locally delivered with
the goal of targeting and delivering radiation to cancer cells while minimizing radiation …

473 Objectives: Internal radiation dosimetry is critical for the development of new diagnostic
imaging radiotracers as well as therapeutic applications where dosimetry can be used to …

Ongoing discussion within the nuclear medicine community suggests that all radionuclide
therapies (RNTs) should include posttreatment quantitative dosimetry as part of standard …

Medical internal radiation dosimetry constitutes a fundamental aspect of diagnosis,
treatment, optimization, and safety in nuclear medicine. The MIRD committee of the Society …